Compass Therapeutics (CMPX) Insider Trading & Ownership $2.92 -0.16 (-5.19%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.90 -0.02 (-0.86%) As of 02/21/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Compass Therapeutics (NASDAQ:CMPX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.50%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$2.61 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$62,561.23 Get CMPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Compass Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CMPX Insider Buying and Selling by Quarter Compass Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/10/2023Thomas J SchuetzCEOBuy10,000$3.37$33,700.00 2/27/2023Thomas J SchuetzCEOBuy20,000$3.98$79,600.00 2/15/2023Thomas J SchuetzCEOBuy20,000$3.86$77,200.00 1/31/2023Thomas J SchuetzCEOBuy20,000$4.05$81,000.00 1/24/2023Thomas J SchuetzCEOBuy20,000$4.19$83,800.00 11/25/2022Vered Bisker-LeibCOOSell2$4.36$8.72 11/22/2022Vered Bisker-LeibCOOSell14,929$4.19$62,552.51 11/8/2022Orbimed Advisors LlcDirectorBuy402,000$3.21$1,290,420.00 9/28/2022Thomas J SchuetzCEOBuy10,000$2.32$23,200.00 9/26/2022Thomas J SchuetzCEOBuy15,000$2.27$34,050.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/10/2022Thomas J SchuetzCEOBuy15,000$2.64$39,600.00 8/1/2022Thomas J SchuetzCEOBuy15,000$2.58$38,700.00 6/21/2022Thomas J SchuetzCEOBuy20,000$2.80$56,000.00 6/16/2022Thomas J SchuetzCEOBuy20,000$2.34$46,800.00 6/13/2022Thomas J SchuetzCEOBuy30,000$2.29$68,700.00 6/6/2022Thomas J SchuetzCEOBuy30,000$2.83$84,900.00 6/1/2022Thomas J SchuetzCEOBuy20,000$3.03$60,600.00 5/26/2022Thomas J SchuetzCEOBuy20,000$3.04$60,800.00 5/23/2022Thomas J SchuetzCEOBuy18,355$2.72$49,925.60 5/13/2022Carl L GordonDirectorBuy30,722$2.49$76,497.78 5/11/2022Carl L GordonDirectorBuy64,700$1.79$115,813.00 5/10/2022Thomas J SchuetzCEOBuy27,836$1.80$50,104.80 5/9/2022Orbimed Advisors LlcDirectorBuy90,712$1.56$141,510.72 5/6/2022Orbimed Advisors LlcDirectorBuy10,200$1.63$16,626.00 (Data available from 1/1/2013 forward) CMPX Insider Trading Activity - Frequently Asked Questions Who is on Compass Therapeutics's Insider Roster? The list of insiders at Compass Therapeutics includes Carl L Gordon, Orbimed Advisors Llc, Thomas J Schuetz, and Vered Bisker-Leib. Learn more on insiders at CMPX. What percentage of Compass Therapeutics stock is owned by insiders? 28.50% of Compass Therapeutics stock is owned by insiders. Learn more on CMPX's insider holdings. Which Compass Therapeutics insiders have been buying company stock? The following insider purchased CMPX shares in the last 24 months: Thomas J Schuetz ($113,300.00). How much insider buying is happening at Compass Therapeutics? Insiders have purchased a total of 30,000 CMPX shares in the last 24 months for a total of $113,300.00 bought. Compass Therapeutics Key ExecutivesDr. Vered Bisker-Leib M.D. (Age 53)MBA, Ph.D., CEO & Director Compensation: $719kDr. Thomas J. Schuetz M.D. (Age 63)Ph.D., Co-Founder, President of Research & Development and Vice Chairman of the Board Compensation: $835.88kMr. Neil L. Lerner CPA (Age 57)Vice President of Finance Mr. Jonathan Anderman J.D.VP, Head of Legal & Corporate SecretaryAnna GiffordCommunications ManagerDr. Minori Rosales M.D. (Age 61)Ph.D., Senior VP & Head of Clinical Development Ms. Karin Herrera B.A.VP & Head of Clinical OperationsDr. James Kranz Ph.D.VP and Head of Chemistry Manufacturing & Controls More Insider Trading Tools from MarketBeat Related Companies NAMS Insider Trades IDYA Insider Trades SDGR Insider Trades TVTX Insider Trades VERA Insider Trades IOVA Insider Trades PRAX Insider Trades WVE Insider Trades APGE Insider Trades IRON Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:CMPX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compass Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMPX Stock Alerts